Loading...
XKRX
060280
Market cap221mUSD
Jul 10, Last price  
8,710.00KRW
1D
6.74%
1Q
-40.75%
Jan 2017
68.47%
IPO
147.44%
Name

Curexo Inc

Chart & Performance

D1W1MN
XKRX:060280 chart
P/E
128.13
P/S
4.79
EPS
67.98
Div Yield, %
Shrs. gr., 5y
4.25%
Rev. gr., 5y
13.67%
Revenues
74.54b
+34.24%
30,060,746,64633,483,881,99333,889,685,07734,388,092,88039,281,591,87742,794,971,25464,990,651,00072,882,216,00055,531,259,00074,544,580,000
Net income
2.78b
P
24,150,571,396-16,884,517,860-29,420,160,861-25,918,256,722416,632,060-2,341,879,864-3,040,885,000-4,856,019,000-8,757,928,0002,784,193,000
CFO
-11.26b
L
-39,219,705,182-1,517,772,230-15,203,767,992-5,075,309,978-1,529,967,111-8,742,050,000-13,082,529,0005,080,266,0003,849,797,000-11,258,379,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CUREXO, Inc. specializes in the creation and distribution of medical technology. The company's activities are organized across three primary divisions: Medical Robot, Implant, and Trade. Its Medical Robot segment focuses on advanced robotic systems designed for surgical procedures, such as joint replacement and spinal operations, in addition to rehabilitation robots and other specialized medical devices. The Implant division is dedicated to manufacturing artificial joint prostheses and a range of other internal body implants. A unique aspect of the company is its Trade division, which manages the import and sale of food products. CUREXO was established on February 29, 1992, and its main offices are situated in Seoul, South Korea.
IPO date
Jul 03, 2002
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT